Among them, LINC00942 exerts its functions as an oncogene in promoting METTL14-mediated m6A methylation and regulating the expression and stability of its target genes CXCR4 and CYP1B1 in breast cancer (BRCA) initiation and progression, which provides new targets and crosstalk m6A epigenetic modification mechanism for BRCA prevention and treatment [28]. This evidence concerns the gene CXCR4 and breast carcinoma.